It is worth mentioning that therapeutic strategies based on JAK/STAT inhibition have shown success in promoting apoptosis and anti-proliferative activities in SCC, suggesting that these pathways are the potential target sites for the treatment of lung cancers, including NSCLC and SCLC (He et al., 2004). The gene discussed is SOAT1; the disease is lung cancer.